Stockscreener 앱 받기
3.77
3.58%
-0.14
Lifemd Inc 주식(LFMD)의 최신 뉴스
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
LifeMD adds Eli Lilly’s oral weight loss drug to platform By Investing.com - Investing.com Canada
LifeMD adds Eli Lilly’s oral weight loss drug to platform - Investing.com
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management - ChartMill
Dividend Watch: How sensitive is LifeMD Inc to inflation2026 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
LifeMD (NASDAQ:LFMD) Trading Down 4.2%What's Next? - MarketBeat
Big Money Moves: Why is LifeMD Inc stock going up2026 Market Outlook & Fast Moving Stock Trade Plans - baoquankhu1.vn
LFMD Technical Analysis & Stock Price Forecast - Intellectia AI
LifeMD Earnings Call Highlights Aggressive Growth Push - TipRanks
LifeMD, Inc. (LFMDP) Stock Price, News, Quote & History - Yahoo! Finance Canada
LFMDP SEC FilingsLifemd, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
200,000 LifeMD (LFMD) RSUs awarded to marketing head - Stock Titan
[Form 3] LifeMD, Inc. Initial Statement of Beneficial Ownership - Stock Titan
LifeMD (LFMD) CFO Atul Kavthekar listed as reporting person in Form 3 - Stock Titan
LifeMD launches Wegovy subscription program with Novo Nordisk By Investing.com - Investing.com South Africa
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program - bitget.com
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Benzinga
NVO: Novo Nordisk's Wegovy Subscription Program Launches with Li - GuruFocus
LifeMD launches Wegovy subscription program with Novo Nordisk - Investing.com
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program - marketscreener.com
Up to $1,200 off Wegovy: LifeMD launches Novo telehealth plan - Stock Titan
Novo to sell Wegovy subscriptions on Hims, LifeMD, and others - Seeking Alpha
Earnings Miss: Why is LifeMD Inc stock going up2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
LifeMD’s GLP-1 Growth Looks Real, But The Stock’s Still Cheap - Finimize
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients - MSN
LifeMD: Comparing The High Yield Preferred Stock To An Options Income Strategy (LFMD) - Seeking Alpha
LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend - MSN
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
How Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Affects Rotational Strategy Timing - Stock Traders Daily
Hims & Hers Expands Integrated Digital Healthcare Ecosystem - tradingview.com
[144] LifeMD, Inc. SEC Filing - Stock Titan
LifeMD appoints Atul Kavthekar as CFO - MSN
If You Invested $1,000 in Lifemd, Inc. (LFMDP) - Stock Titan
If You Invested $1,000 in Lifemd Inc (LFMD) - Stock Titan
LifeMD appoints new CFO; shares up - MSN
How The LifeMD (LFMD) Story Is Shifting On GLP‑1 Growth And Higher 2026 Targets - Yahoo Finance
LifeMD Appoints Atul Kavthekar as CFO and Expands Leadership Team to Drive AI-First Healthcare Growth 1 - Minichart
LifeMD Announces CFO Transition and Expanded Leadership Team - TipRanks
LifeMD (NASDAQ: LFMD) installs new CFO and expands leadership team - Stock Titan
LifeMD (LFMD) to Participate in B. Riley's Virtual Meeting on Ma - GuruFocus
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG) - The Globe and Mail
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LifeMD names Atul Kavthekar as CFO, announces leadership changes By Investing.com - Investing.com India
LifeMD, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Lifemd, Inc. Announces Executive Appointments - marketscreener.com
LifeMD shares are trading higher after the co... - Benzinga
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team - markets.businessinsider.com
0.48%
1.81%
자본화:
|
볼륨(24시간):